ERBB2 and breast carcinoma: Breast cancer represents a heterogeneous disease and the currently most relevant clinical classification is based on the expression of the estrogen receptor (ER), progesteron receptor (PgR), as well as the human epidermal growth factor receptor 2 (HER2) [1], [2].